Literature DB >> 16481724

Thalidomide: current status.

Prashasti S Shanbhag1, Vishalakshi Viswanath, R G Torsekar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16481724     DOI： 10.4103/0378-6323.19732

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN： 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  2 in total

1.  Thalidomide attenuates the hyporesponsiveness of isolated atria to chronotropic stimulation in BDL rats: The involvement of TNF-α, IL-6 inhibition, and SOCS1 activation.

Authors:  Ali Hosseini-Chegeni; Farahnaz Jazaeri; Aliakbar Yousefi-Ahmadipour; Mansour Heidari; Alireza Abdollahie; Ahmad Reza Dehpour
Journal:  Iran J Basic Med Sci       Date:  2019-11       Impact factor: 2.699

2.  The Dermlep Study Part 2: Results of a Nation-Wide Survey of Dermatologists' Access to Quality Leprosy Services at their Clinics and Hospitals in India.

Authors:  P Narasimha Rao; Santoshdev Rathod; Sujai Suneetha; Sunil Dogra; Rita Vora; Sunil Kumar Gupta
Journal:  Indian Dermatol Online J       Date:  2020-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.